MBiochem, Molecular and Cellular Biochemistry, University of Oxford
“Novasecta’s ability to draw upon a deep understanding of the pharmaceutical and biotech industries, in combination with a bespoke, collaborative approach to solving clients’ problems, makes it a truly exciting place to learn and develop. I am proud to be part of a company so dedicated to improving the strategy and outlook of their clients, a commitment which undoubtedly delivers value to patients further down the line.”
Alex works across operating models and decision making in biotech and pharmaceutical companies.
He has recently completed his Masters project, using in silico modelling to investigate novel mechanisms of bacterial resistance to antibiotics.